| dc.creator | González C,Carlos | |
| dc.creator | García C,Apolinaria | |
| dc.creator | Daroch M,Fabiola | |
| dc.creator | Kawaguchi P,Fernando | |
| dc.creator | Solar R,Henry | |
| dc.creator | Rivera F,Nancy | |
| dc.creator | Vega C,Edith | |
| dc.date | 2001-06-01 | |
| dc.date.accessioned | 2020-02-17T15:26:45Z | |
| dc.date.available | 2020-02-17T15:26:45Z | |
| dc.identifier | https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000600007 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/126932 | |
| dc.description | Background: Our laboratory has carried out an epidemiological surveillance of Helicobacter pylori antimicrobial susceptibility since 1997. Aim: To report the antimicrobial susceptibility of H pylori strains, isolated in Chile from August 1997 to August 2000. Material and methods: Ninety one H pylori strains, obtained from antral gastric biopsies during upper gastrointestinal endoscopies were studied. Susceptibility towards clarithromycin, amoxicillin, bismuth subcitrate and metronidazole was studied by an agar diffusion technique. Results: All strains were susceptible to amoxicillin and two strains were resistant to clarithromycin. Forty two percent of strains were resistant to metronidazole and 13% were resistant to bismuth subcitrate. Conclusions: These results underscore the need to maintain an epidemiological surveillance of H pylori antimicrobial susceptibility, to modify its eradication therapy accordingly. (Rev Méd Chile 2000; 129; 643-6 | |
| dc.format | text/html | |
| dc.language | es | |
| dc.publisher | Sociedad Médica de Santiago | |
| dc.relation | 10.4067/S0034-98872001000600007 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | Revista médica de Chile v.129 n.6 2001 | |
| dc.subject | Amoxicillin | |
| dc.subject | Antibiotics | |
| dc.subject | Bismuth | |
| dc.subject | Helicobacter pylori | |
| dc.subject | Metronidazole | |
| dc.title | Susceptibilidad in vitro de cepas de Helicobacter pylori: aislamiento de cepas resistentes a claritromicina | |
